Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.

MLA

Thomas, Rhian S., et al. “Alterations in Endocytic Protein Expression with Increasing Age in the Transgenic APP695 V717I London Mouse Model of Amyloid Pathology: Implications for Alzheimer’s Disease.” Neuroreport, vol. 28, no. 15, Oct. 2017, pp. 963–68. EBSCOhost, https://doi.org/10.1097/WNR.0000000000000861.

APA

Thomas, R. S., Alsaqati, M., Bice, J. S., Hvoslef-Eide, M., Good, M. A., & Kidd, E. J. (2017). Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer’s disease. Neuroreport, 28(15), 963–968. https://doi.org/10.1097/WNR.0000000000000861

Chicago

Thomas, Rhian S, Mouhamed Alsaqati, Justin S Bice, Martha Hvoslef-Eide, Mark A Good, and Emma J Kidd. 2017. “Alterations in Endocytic Protein Expression with Increasing Age in the Transgenic APP695 V717I London Mouse Model of Amyloid Pathology: Implications for Alzheimer’s Disease.” Neuroreport 28 (15): 963–68. doi:10.1097/WNR.0000000000000861.